Document is current
Any future updates will be listed below
-
Authors
Yang, Ren https://orcid.org/0000-0002-8134-4010
Deng, Yao
Huang, Baoying
Huang, Lei
Lin, Ang https://orcid.org/0000-0001-5662-1576
Li, Yuhua
Wang, Wenling
Liu, Jingjing
Lu, Shuaiyao
Zhan, Zhenzhen
Wang, Yufei
A, Ruhan
Wang, Wen
Niu, Peihua
Zhao, Li
Li, Shiqiang
Ma, Xiaopin
Zhang, Luyao
Zhang, Yujian
Yao, Weiguo
Liang, Xingjie
Zhao, Jincun https://orcid.org/0000-0003-2515-5589
Liu, Zhongmin
Peng, Xiaozhong https://orcid.org/0000-0002-8564-0247
Li, Hangwen
Tan, Wenjie
- License Information
-
More Information
Article History
Received: 10 March 2021
Revised: 17 April 2021
Accepted: 5 May 2021
First Online: 31 May 2021
Competing interests
: Stemirna Therapeutics filed patents on patent application entitled “A prophylactic or therapeutical 2019-nCoV mRNA vaccine”. All other authors declare no conflict of interest.
